tetano
Editor, Senior Moderator
Lancet Reg Health Southeast Asia
. 2025 Sep 10:41:100663.
doi: 10.1016/j.lansea.2025.100663. eCollection 2025 Oct.
Influenza surveillance and vaccine policy in Thailand-a historical perspective
Martha P Montgomery[SUP] 1 2 [/SUP], Prabda Praphasiri[SUP] 1 [/SUP], Darunee Ditsungnoen[SUP] 1 [/SUP], Pasakorn Akarasewi[SUP] 3 [/SUP], Malinee Chittaganpitch[SUP] 4 [/SUP], Pilaipan Puthavathana[SUP] 5 [/SUP], Khanchit Limpakarnjanarat[SUP] 3 [/SUP], Ponthip Wirachwong[SUP] 6 [/SUP], Tawee Chotpitayasunondh[SUP] 7 [/SUP], Narumol Sawanpanyalert[SUP] 8 [/SUP], Chaninan Sonthichai[SUP] 1 [/SUP], William W Davis[SUP] 1 2 [/SUP], Sonja J Olsen[SUP] 2 [/SUP], Supamit Chunsuttiwat[SUP] 3 [/SUP]
Affiliations
Prior to 2000, influenza burden in Thailand and other low- and middle-income countries was underappreciated, and influenza vaccination was uncommon. For the last two decades, Thailand Ministry of Public Health (MOPH) and U.S. Centers for Disease Control and Prevention have collaborated to understand influenza burden and the costs and benefits of influenza vaccination in Thailand. Built on a long-standing national disease notification system, Thailand MOPH established robust surveillance platforms for pneumonia and influenza, which provided insights into seasonality, disease incidence, and populations at risk for severe disease. In 2004, human cases of avian influenza brought attention to influenza's pandemic potential. Concern for an influenza pandemic combined with evidence of the cost effectiveness of influenza vaccination accelerated vaccine policy. Surveillance and vaccination policy were leveraged for and strengthened by the 2009 influenza H1N1 and COVID-19 pandemics. This personal view documents Thailand's experience in developing influenza surveillance and influenza vaccination policy.
Keywords: Influenza; Surveillance; Thailand; Vaccination.
. 2025 Sep 10:41:100663.
doi: 10.1016/j.lansea.2025.100663. eCollection 2025 Oct.
Influenza surveillance and vaccine policy in Thailand-a historical perspective
Martha P Montgomery[SUP] 1 2 [/SUP], Prabda Praphasiri[SUP] 1 [/SUP], Darunee Ditsungnoen[SUP] 1 [/SUP], Pasakorn Akarasewi[SUP] 3 [/SUP], Malinee Chittaganpitch[SUP] 4 [/SUP], Pilaipan Puthavathana[SUP] 5 [/SUP], Khanchit Limpakarnjanarat[SUP] 3 [/SUP], Ponthip Wirachwong[SUP] 6 [/SUP], Tawee Chotpitayasunondh[SUP] 7 [/SUP], Narumol Sawanpanyalert[SUP] 8 [/SUP], Chaninan Sonthichai[SUP] 1 [/SUP], William W Davis[SUP] 1 2 [/SUP], Sonja J Olsen[SUP] 2 [/SUP], Supamit Chunsuttiwat[SUP] 3 [/SUP]
Affiliations
- PMID: 41635704
- PMCID: PMC12862145
- DOI: 10.1016/j.lansea.2025.100663
Prior to 2000, influenza burden in Thailand and other low- and middle-income countries was underappreciated, and influenza vaccination was uncommon. For the last two decades, Thailand Ministry of Public Health (MOPH) and U.S. Centers for Disease Control and Prevention have collaborated to understand influenza burden and the costs and benefits of influenza vaccination in Thailand. Built on a long-standing national disease notification system, Thailand MOPH established robust surveillance platforms for pneumonia and influenza, which provided insights into seasonality, disease incidence, and populations at risk for severe disease. In 2004, human cases of avian influenza brought attention to influenza's pandemic potential. Concern for an influenza pandemic combined with evidence of the cost effectiveness of influenza vaccination accelerated vaccine policy. Surveillance and vaccination policy were leveraged for and strengthened by the 2009 influenza H1N1 and COVID-19 pandemics. This personal view documents Thailand's experience in developing influenza surveillance and influenza vaccination policy.
Keywords: Influenza; Surveillance; Thailand; Vaccination.